Firstly in the Correction to Notice of General Meeting nowhere...

Firstly in the Correction to Notice of General Meeting nowhere does it state that Sud tried to block the acquisition, it simply stated he was not present due to other commitments (conveniently you left that last bit un-highlighted). How are you arriving at the conclusion he tried to block it? Just guessing?

Secondly the screenshot you provided of the Correction to Meeting states that “the recommendations should not have been referred to as unanimous at that time”. This to me suggests it became unanimous at a later date after the meeting but before the release of the correction. But I’m sure what the wording actually means could be argued until the cows come home.

Also your suggestion Sud started selling his large shareholding one month after the APIRx deal was completed is false.

The results of meeting in which APIRx deal was voted in favour of was 9^th June 2022. Is this when you consider the acquisition becoming official?

https://stocknessmonster.com/announcements/ihl.asx-3A595209/

Sud’s resignation was announced on the 28^th June, 2022.

https://stocknessmonster.com/announcements/ihl.asx-3A596222/

In the “Directors Initial and Final Interest Notice”released 29^th June 2022, Sud held 75.3million shares.

https://stocknessmonster.com/announcements/ihl.asx-3A596298/

In the 2022 Annual report released 20^th Sept 2022 with data as at 22^nd Aug 2022 (2 months after Sud’s resignation) Sud still held 75.3million shares. Hadn’t sold a single share.

https://stocknessmonster.com/announcements/ihl.asx-3A602642/

One year on from that report in the 2023 Annual report, as of 30^th Aug 2023, Sud still held 34million shares (so granted he had sold off a bit over half his holding throughout that year) but his company Cannvalate hadn’t sold a single share, still holding 32million.

https://stocknessmonster.com/announcements/ihl.asx-3A624879/

Sud’s sell off seems to align more with his personal legal proceedings in the US and IHL’s redomicile to the US than it does with the APIRx acquisition. If it was to do with APIRx acquisition why wouldn’t Cannvalate also sell down their holding as soon as that deal was approved? I think you're clutching at straws trying to link the APIRx deal with Sud's resignation and him selling off shares at some point in the year or so that followed.

Also is there any evidence Sud sold the remainder of those 34million shares prior to the redomicile?

Is there any evidence Cannvalate sold a single share prior to the redomicile?

I know there was lots of speculation they did, but any actual evidence I’m missing?

I don't disagree that the APIRx deal has been a bit of a let down since it happened, we've heard basically nothing about it as you've pointed out. But don't try and link it with Sud's departure from IHL. You're motive is clearly your ongoing feud with JMiller.